Showing results (91-100 of 154) with videos related to

Sort By:
Pageof 16
Biochemical and Biophysical Research Communications|July 19, 2005
Cloning and expression of Ca2+-activated chloride channel from rat brainSang Min Jeong, Hye-Kyung Park, In-Soo Yoon, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|February 13, 2010
Preparation and evaluation of spray-dried hyaluronic acid microspheres for intranasal delivery of fexofenadine hydrochlorideYeamin Huh, Hyun-Jong Cho, In-Soo Yoon, et al.
Drug Development Research|February 22, 2023
Investigation of the factors responsible for the low oral bioavailability of alizarin using a sensitive LC-MS/MS method: In vitro, in situ, and in vivo evaluationsSeong-Wook Seo, Dong-Gyun Han, Young Mee Baek, et al.
Pharmaceutics|December 15, 2019
In Vitro and In Vivo Assessment of Metabolic Drug Interaction Potential of Dutasteride with KetoconazoleSeong-Wook Seo, Jin Woo Park, Dong-Gyun Han, et al.
Planta Medica|September 15, 2015
Vitamin D Receptor-Mediated Upregulation of CYP3A4 and MDR1 by Quercetin in Caco-2 cellsYoon-Jee Chae, Kwan Hyung Cho, In-Soo Yoon, et al.
Carbohydrate Polymers|January 1, 2020
Blood component ridable and CD44 receptor targetable nanoparticles based on a maleimide-functionalized chondroitin sulfate derivativeJae-Young Lee, Han Sol Lee, Nae-Won Kang, et al.
Biopharmaceutics & Drug Disposition|February 11, 2016
High body clearance and low oral bioavailability of alantolactone, isolated from Inula helenium, in rats: extensive hepatic metabolism and low stability in gastrointestinal fluidsJae-Young Lee, Sang-Bum Kim, Jaemoo Chun, et al.
Pharmaceutics|February 2, 2021
Investigation of the Factors Responsible for the Poor Oral Bioavailability of Acacetin in Rats: Physicochemical and Biopharmaceutical AspectsDong-Gyun Han, Eunju Cha, Jeongmin Joo, et al.
Planta Medica|April 9, 2014
In vitro and in vivo evaluation of the effect of puerarin on hepatic cytochrome p450-mediated drug metabolismSang-Bum Kim, In-Soo Yoon, Kyu-Sang Kim, et al.
Pharmaceutics|September 9, 2020
A Colon-Targeted Prodrug, 4-Phenylbutyric Acid-Glutamic Acid Conjugate, Ameliorates 2,4-Dinitrobenzenesulfonic Acid-Induced Colitis in RatsSoojin Kim, Seunghyun Lee, Hanju Lee, et al.
Pageof 16